ClinicalTrials.gg
Sign In

Disruptive, Impulse Control, and Conduct Disorders clinical trials

The registry lists 56 studies for Disruptive, Impulse Control, and Conduct Disorders across more than 10 countries. 17 are recruiting or about to start. 24 of them are mainly about Disruptive, Impulse Control, and Conduct Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-22. Counting its 3 narrower conditions too, such as Gambling: 261 studies, 67 open.

Get an email when these change. Save the Disruptive, Impulse Control, and Conduct Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
28
Recruiting
15
Status unknown
7
Terminated
3
Not yet recruiting
1
Active, not recruiting
1

Phase

Phase 2
18
Phase 4
7
Phase 3
4
Phase 1
3

Where

United States
31
France
12
Switzerland
4
Netherlands
3
Germany
3
United Kingdom
1

Who runs them

University of Chicago (7) · Ohio State University (5) · University Hospital, Clermont-Ferrand (4) · University of Minnesota (3) · University Hospital, Strasbourg, France (2) · Hospices Civils de Lyon (2) · Boehringer Ingelheim (2) · Assistance Publique - Hôpitaux de Paris (2)

What is being tested here

Drugs under test in Disruptive, Impulse Control, and Conduct Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pimavanserin102
Endotoxins101
Ethanol101
Nitrous Oxide101
Naltrexone003
Acetylcysteine002
Clonidine001
SRX246001
Inositol001
Memantine001

Drug classes tested here Antipsychotics 1 open · Opioid antagonists 4 · SSRIs 3

Coming up

1phase 3 study under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 15 Disruptive, Impulse Control, and Conduct Disorders studies recruiting now, 4 (27%) set no upper age limit and 10 (67%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (33%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
100 (0%)0 (0%)
188 (53%)8 (53%)
3014 (93%)14 (93%)
4014 (93%)14 (93%)
5015 (100%)15 (100%)
659 (60%)9 (60%)
756 (40%)6 (40%)
854 (27%)4 (27%)

Across all 56 studies, recruiting or not: 71% stop at 75 or younger and 54% at 65; 13% take children; 0% are for women only and 2% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 56. Browse all 56 → or search them.